276 related articles for article (PubMed ID: 28839258)
21. Myoglobin variants are expressed in human glioblastoma cells‑hypoxia effect?
El-Tohamy R; Elkholi I; Elsherbiny ME; Magdy M; Hammam O; Allalunis-Turner J; Emara M
Oncol Rep; 2020 Mar; 43(3):975-985. PubMed ID: 32020230
[TBL] [Abstract][Full Text] [Related]
22. ATP binding cassette (ABC) transporters: expression and clinical value in glioblastoma.
Dréan A; Rosenberg S; Lejeune FX; Goli L; Nadaradjane AA; Guehennec J; Schmitt C; Verreault M; Bielle F; Mokhtari K; Sanson M; Carpentier A; Delattre JY; Idbaih A
J Neurooncol; 2018 Jul; 138(3):479-486. PubMed ID: 29520610
[TBL] [Abstract][Full Text] [Related]
23. Aspirin Affects Tumor Angiogenesis and Sensitizes Human Glioblastoma Endothelial Cells to Temozolomide, Bevacizumab, and Sunitinib, Impairing Vascular Endothelial Growth Factor-Related Signaling.
Navone SE; Guarnaccia L; Cordiglieri C; Crisà FM; Caroli M; Locatelli M; Schisano L; Rampini P; Miozzo M; La Verde N; Riboni L; Campanella R; Marfia G
World Neurosurg; 2018 Dec; 120():e380-e391. PubMed ID: 30144594
[TBL] [Abstract][Full Text] [Related]
24. Proteomics-based prognostic signature and nomogram construction of hypoxia microenvironment on deteriorating glioblastoma (GBM) pathogenesis.
Wen YD; Zhu XS; Li DJ; Zhao Q; Cheng Q; Peng Y
Sci Rep; 2021 Aug; 11(1):17170. PubMed ID: 34446747
[TBL] [Abstract][Full Text] [Related]
25. EGFRvIII/integrin β3 interaction in hypoxic and vitronectinenriching microenvironment promote GBM progression and metastasis.
Liu Z; Han L; Dong Y; Tan Y; Li Y; Zhao M; Xie H; Ju H; Wang H; Zhao Y; Zheng Q; Wang Q; Su J; Fang C; Fu S; Jiang T; Liu J; Li X; Kang C; Ren H
Oncotarget; 2016 Jan; 7(4):4680-94. PubMed ID: 26717039
[TBL] [Abstract][Full Text] [Related]
26. Dual blockage of STAT3 and ERK1/2 eliminates radioresistant GBM cells.
Xie B; Zhang L; Hu W; Fan M; Jiang N; Duan Y; Jing D; Xiao W; Fragoso RC; Lam KS; Sun LQ; Li JJ
Redox Biol; 2019 Jun; 24():101189. PubMed ID: 30986607
[TBL] [Abstract][Full Text] [Related]
27. Peroxisome proliferator-activated receptor gamma as a theragnostic target for mesenchymal-type glioblastoma patients.
Hua TNM; Oh J; Kim S; Antonio JM; Vo VTA; Om J; Choi JW; Kim JY; Jung CW; Park MJ; Jeong Y
Exp Mol Med; 2020 Apr; 52(4):629-642. PubMed ID: 32280134
[TBL] [Abstract][Full Text] [Related]
28. Analysis of the cancer genome atlas (TCGA) database identifies an inverse relationship between interleukin-13 receptor α1 and α2 gene expression and poor prognosis and drug resistance in subjects with glioblastoma multiforme.
Han J; Puri RK
J Neurooncol; 2018 Feb; 136(3):463-474. PubMed ID: 29168083
[TBL] [Abstract][Full Text] [Related]
29. HIF1α regulates single differentiated glioma cell dedifferentiation to stem-like cell phenotypes with high tumorigenic potential under hypoxia.
Wang P; Lan C; Xiong S; Zhao X; Shan Y; Hu R; Wan W; Yu S; Liao B; Li G; Wang J; Zou D; Chen B; Feng H; Wu N
Oncotarget; 2017 Apr; 8(17):28074-28092. PubMed ID: 28427209
[TBL] [Abstract][Full Text] [Related]
30. The Impact of Hypoxia and Mesenchymal Transition on Glioblastoma Pathogenesis and Cancer Stem Cells Regulation.
Karsy M; Guan J; Jensen R; Huang LE; Colman H
World Neurosurg; 2016 Apr; 88():222-236. PubMed ID: 26724617
[TBL] [Abstract][Full Text] [Related]
31. γ-Glutamyl transferase 7 is a novel regulator of glioblastoma growth.
Bui TT; Nitta RT; Kahn SA; Razavi SM; Agarwal M; Aujla P; Gholamin S; Recht L; Li G
BMC Cancer; 2015 Apr; 15():225. PubMed ID: 25884624
[TBL] [Abstract][Full Text] [Related]
32. Knockdown of NAT12/NAA30 reduces tumorigenic features of glioblastoma-initiating cells.
Mughal AA; Grieg Z; Skjellegrind H; Fayzullin A; Lamkhannat M; Joel M; Ahmed MS; Murrell W; Vik-Mo EO; Langmoen IA; Stangeland B
Mol Cancer; 2015 Aug; 14():160. PubMed ID: 26292663
[TBL] [Abstract][Full Text] [Related]
33. The Chromatin-Oxygen Sensor Gene
Drongitis D; Verrillo L; De Marinis P; Orabona P; Caiola A; Turitto G; Alfieri A; Bruscella S; Gentile M; Moriello V; Sannino E; Di Muccio I; Costa V; Miano MG; de Bellis A
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142158
[TBL] [Abstract][Full Text] [Related]
34. Establishment and External Validation of a Hypoxia-Derived Gene Signature for Robustly Predicting Prognosis and Therapeutic Responses in Glioblastoma Multiforme.
Wang K; Lu Y; Liu Z; Diao M; Yang L
Biomed Res Int; 2022; 2022():7858477. PubMed ID: 35155681
[TBL] [Abstract][Full Text] [Related]
35.
Gonçalves CS; Vieira de Castro J; Pojo M; Martins EP; Queirós S; Chautard E; Taipa R; Pires MM; Pinto AA; Pardal F; Custódia C; Faria CC; Clara C; Reis RM; Sousa N; Costa BM
Theranostics; 2018; 8(17):4805-4823. PubMed ID: 30279739
[TBL] [Abstract][Full Text] [Related]
36. p53 and miR-210 regulated NeuroD2, a neuronal basic helix-loop-helix transcription factor, is downregulated in glioblastoma patients and functions as a tumor suppressor under hypoxic microenvironment.
Agrawal R; Garg A; Benny Malgulwar P; Sharma V; Sarkar C; Kulshreshtha R
Int J Cancer; 2018 May; 142(9):1817-1828. PubMed ID: 29226333
[TBL] [Abstract][Full Text] [Related]
37. LncRNA-FAM66C Was Identified as a Key Regulator for Modulating Tumor Microenvironment and Hypoxia-Related Pathways in Glioblastoma.
Liu D; Wan Y; Qu N; Fu Q; Liang C; Zeng L; Yang Y
Front Public Health; 2022; 10():898270. PubMed ID: 35874989
[TBL] [Abstract][Full Text] [Related]
38. Astrocyte-derived CCL20 reinforces HIF-1-mediated hypoxic responses in glioblastoma by stimulating the CCR6-NF-κB signaling pathway.
Jin P; Shin SH; Chun YS; Shin HW; Shin YJ; Lee Y; Kim D; Nam DH; Park JW
Oncogene; 2018 Jun; 37(23):3070-3087. PubMed ID: 29535421
[TBL] [Abstract][Full Text] [Related]
39. MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression.
Chen W; Xu XK; Li JL; Kong KK; Li H; Chen C; He J; Wang F; Li P; Ge XS; Li FC
Oncotarget; 2017 Apr; 8(14):22783-22799. PubMed ID: 28187000
[TBL] [Abstract][Full Text] [Related]
40. The tumor microenvironment strongly impacts master transcriptional regulators and gene expression class of glioblastoma.
Cooper LA; Gutman DA; Chisolm C; Appin C; Kong J; Rong Y; Kurc T; Van Meir EG; Saltz JH; Moreno CS; Brat DJ
Am J Pathol; 2012 May; 180(5):2108-19. PubMed ID: 22440258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
